Peiwen Chen, Ph.D., Postdoctoral FellowThe University of Texas MD Anderson Cancer Center

Supported by CRI, I hope to Make Glioblastoma History by developing novel immunotherapy strategies.
Area of Research: Brain Cancer

Glioblastoma is the most lethal form of brain cancer in adults. Due to the ineffectiveness of current treatments, Dr. Peiwen Chen’s goal is to figure out how immune cells might be more effectively employed in targeting and eliminating brain cancer cells. Specifically, Dr. Chen aims to identify which genetic events in the cancer cells drive immune responses in glioblastoma, and to determine which immune cells are affected in this process. By characterizing the mechanisms that underlie this communication between cancer cells and immune cells in the tumor environment as well as the roles that individual genes play in this behavior, Dr. Chen hopes to uncover insights that can be used to develop novel immunotherapy strategies against this feedback loop and improve outcomes for these patients with glioblastoma.

Projects and Grants

Mechanism and therapeutic potential of PTEN-regulated macrophages in glioblastoma

The University of Texas MD Anderson Cancer Center | Brain Cancer | 2018 | Ronald A. DePinho, M.D.

Let's spread the word about Immunotherapy! Click to share this page with your community.
Copy Link

*Immunotherapy results may vary from patient to patient.